Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.71T | 1.64T | 1.40T | 1.03T | 898.17B |
Gross Profit | 418.18B | 395.45B | 268.70B | 43.25B | -77.42B |
EBITDA | 353.35B | 328.61B | 245.33B | 61.27B | -72.08B |
Net Income | 113.96B | 98.76B | 88.53B | -113.20B | -233.21B |
Balance Sheet | |||||
Total Assets | 3.75T | 3.78T | 3.74T | 3.70T | 3.48T |
Cash, Cash Equivalents and Short-Term Investments | 125.62B | 233.47B | 290.17B | 319.92B | 210.31B |
Total Debt | 1.44T | 1.48T | 1.57T | 1.64T | 1.48T |
Total Liabilities | 2.47T | 2.55T | 2.59T | 2.63T | 2.52T |
Stockholders Equity | 1.16T | 1.11T | 1.03T | 968.94B | 852.91B |
Cash Flow | |||||
Free Cash Flow | 281.43B | 68.96B | 27.95B | -326.95B | -345.34B |
Operating Cash Flow | 281.43B | 318.31B | 273.96B | -86.47B | -103.30B |
Investing Cash Flow | -263.11B | -243.65B | -214.90B | -188.71B | -211.69B |
Financing Cash Flow | -126.17B | -131.62B | -88.77B | 384.69B | 446.75B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $36.26B | 33.22 | 10.62% | 0.47% | 5.21% | 24.15% | |
80 Outperform | $62.37B | 18.89 | 24.52% | 1.95% | 0.70% | 135.08% | |
76 Outperform | $5.50B | 19.51 | 11.64% | 1.58% | 12.07% | 11.93% | |
75 Outperform | $64.60B | 20.49 | 26.13% | 1.51% | -2.39% | -7.80% | |
71 Outperform | $10.14B | 13.70 | 9.93% | 1.54% | -0.78% | 148.74% | |
70 Outperform | $134.35B | 20.26 | 42.47% | 2.38% | 0.63% | 5.93% | |
58 Neutral | HK$14.28B | 4.63 | -3.01% | 6.75% | 3.67% | -54.16% |